Oral tolerance: immune mechanisms and treatment of autoimmune diseases.
about
Immunology and homeopathy. 3. Experimental studies on animal modelsInduction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagenAdvances in immunomodulating therapy of HBV infectionRegulatory T-cells: diverse phenotypes integral to immune homeostasis and suppressionGender-dependent specific immune response during chronic human Schistosomiasis haematobiaMucosal tolerance to E-selectin provides cell-mediated protection against ischemic brain injuryA novel expression platform for the production of diabetes-associated autoantigen human glutamic acid decarboxylase (hGAD65).Reduced expression of transforming growth factor-β1 and correlated elevation of interleukin-17 and interferon-γ in pediatric patients with chronic primary immune thrombocytopenia (ITP).IL-28 supplants requirement for T(reg) cells in protein sigma1-mediated protection against murine experimental autoimmune encephalomyelitis (EAE)An alternative perspective to the immune response in autoimmune exocrinopathy: induction of functional quiescence rather than destructive autoaggression.Oral tolerance with copolymer 1 for the treatment of multiple sclerosis.Mechanisms of central and peripheral T-cell tolerance: lessons from experimental models of multiple sclerosis.Lethal effect of CD3-specific antibody in mice deficient in TGF-beta1 by uncontrolled flu-like syndrome.Humoral immune response to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in periodontal disease.Mucosal immunity and tolerance: relevance to vaccine development.Oral administration of human T-cell leukemia virus type 1 induces immune unresponsiveness with persistent infection in adult rats.Papillomavirus pseudovirus: a novel vaccine to induce mucosal and systemic cytotoxic T-lymphocyte responses.DNA immunization to prevent autoimmune diabetes.Pathways of T cell pathology in models of chronic intestinal inflammation.TNBS-colitis.Chronic colitis in IL-10-/- mice: insufficient counter regulation of a Th1 response.Oral administration of an immunodominant T-cell epitope downregulates Th1/Th2 cytokines and prevents experimental myasthenia gravis.Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment.T-cell regulation of peripheral tolerance and immunity: the potential role for Notch signalling.TGF-beta and 'adaptive' Foxp3(+) regulatory T cells.Oral tolerance.Control of experimental inflammatory bowel disease by regulatory T cells.Therapeutic Efficacy and Safety of Undenatured Type II Collagen Singly or in Combination with Glucosamine and Chondroitin in Arthritic Dogs.Nasal tolerance induction as a potential means of immunotherapy for autoimmune diseases: implications for clinical medicine.Identification of alpha-tropomyosin as a target self-antigen in Behçet's syndrome.Mucosal tolerance to a bacterial superantigen indicates a novel pathway to prevent toxic shock.The causes of the increasing prevalence of allergy: is atopy a microbial deprivation disorder?Targeting ganglioside epitope 3G11 on the surface of CD4+ T cells suppresses EAE by altering the Treg/Th17 cell balanceComparative therapeutic efficacy and safety of type-II collagen (UC-II), glucosamine and chondroitin in arthritic dogs: pain evaluation by ground force plate.Nature and function of gastrointestinal antigen-presenting cells.Novel approaches to the treatment of chronic graft-versus-host disease.Food for thought: can immunological tolerance be induced to treat asthma?The genetic and immunopathological processes underlying collagen-induced arthritis.Vaccines against myasthenia gravis.The immune-enhancing effects of dietary fibres and prebiotics.
P2860
Q24548018-9BE3FE59-89AA-44FC-BE16-6B74C4360A4EQ24800770-DC86B051-2DBD-4A20-94D1-6CFB05B29BCCQ24810147-A6AEA0B2-DCFC-4130-AC0F-3A4937B8FC96Q27022973-F3BF9AB9-7A21-42D0-837A-1EA97A04E95EQ28365400-8BD30A3A-BDAB-4FD5-A27F-75D6E314AEEEQ33195470-F1ED5448-7DBD-48EF-A06D-F78535FE1261Q33385000-F3680693-B103-4B41-AC2C-00983370F91BQ33396043-FBE5AF19-1250-495A-A77D-6AF721841B70Q33525565-E0CE3F06-F4F0-459A-909D-2C615864C484Q33534364-A92D6A37-05C0-4BBE-8A79-733DB5BC9090Q33546205-8F692078-9EEF-4DD6-A820-7B660D76A1F7Q33713307-987F76A3-784C-4E0E-93E5-50B2D531943FQ33743988-8E2D9BEE-E3C5-4ABD-83F7-FAE147D11416Q33752062-D521136D-0683-492D-B0F9-6DB093E4FBE9Q33776172-62025087-0974-4556-9311-3C494DE74DD8Q33783833-5083C163-479C-45AE-A65C-5CF3472CD024Q33847557-498801A5-EDA1-4CCA-B7D7-B1529FAA2317Q33855482-F901DDD3-F687-4F79-BCD2-1AD438CCA771Q33867150-E7192CE0-4787-4B63-8BC8-3CB435364B6AQ33867163-ABC95FD5-83E8-4ABB-A278-F08E60FE5873Q33867180-771288B6-CC68-4551-A9F4-986D58BCF420Q33901936-56E268DC-B224-4057-9D9B-438B99AEB664Q33903455-06AC3DAC-5A01-4455-947A-E126D84564F1Q33992826-34C5FC24-D5ED-4D54-9538-50B4607AA3E3Q33999342-0FEC12C4-2981-4868-BB8B-64CEEE9BF0EFQ34058680-5CDEE245-FD36-41BF-BA2E-B2CCEA9E8D15Q34058688-E41E5F4A-ABEE-4CA3-A690-538E115E38BEQ34088913-90209937-E38C-4874-BBEB-892BAA58E664Q34106906-4F5436C3-61D9-4525-A4A3-306C8B64F8C8Q34110950-E926926C-4D59-4146-9FD5-C03F09DC5277Q34121640-4F7E033D-A121-4543-91EE-590DD8393F91Q34135167-CE422285-1618-4E81-9906-46834ED1E50AQ34157827-3B96AD34-A51E-4310-9B1B-B4F9136FBB3FQ34188301-DC4CC6D2-D06D-4407-BB95-0C17B71E5BC5Q34215953-12DA0506-07AD-4C5F-A071-EC836389CF59Q34232039-830D298E-F7B7-42BD-A3D6-CA5153C2B013Q34249844-EC6682B5-186B-4A78-85DE-163380CD4CECQ34351148-3E5749A6-B89C-4718-A47D-6A7A1FAD8EE1Q34433908-D3B9339F-20A6-4AC6-B811-E2BA9E407A51Q34524687-0F68C12A-0092-4ED4-9EC1-33172E6ED018
P2860
Oral tolerance: immune mechanisms and treatment of autoimmune diseases.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Oral tolerance: immune mechanisms and treatment of autoimmune diseases.
@en
type
label
Oral tolerance: immune mechanisms and treatment of autoimmune diseases.
@en
prefLabel
Oral tolerance: immune mechanisms and treatment of autoimmune diseases.
@en
P1433
P1476
Oral tolerance: immune mechanisms and treatment of autoimmune diseases.
@en
P2093
P304
P356
10.1016/S0167-5699(97)01053-0
P577
1997-07-01T00:00:00Z